1. Home
  2. AMBA vs PBLS Comparison

AMBA vs PBLS Comparison

Compare AMBA & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$62.24

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$28.42

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMBA
PBLS
Founded
2004
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.4B
IPO Year
2011
2026

Fundamental Metrics

Financial Performance
Metric
AMBA
PBLS
Price
$62.24
$28.42
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$97.25
N/A
AVG Volume (30 Days)
1.8M
545.1K
Earning Date
05-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
37.32
N/A
EPS
N/A
N/A
Revenue
$295,402,000.00
N/A
Revenue This Year
$15.03
N/A
Revenue Next Year
$12.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$48.30
$25.56
52 Week High
$96.69
$33.65

Technical Indicators

Market Signals
Indicator
AMBA
PBLS
Relative Strength Index (RSI) 41.03 52.17
Support Level $49.58 $26.96
Resistance Level $71.02 $30.90
Average True Range (ATR) 7.99 2.39
MACD -1.33 -0.05
Stochastic Oscillator 9.15 30.56

Price Performance

Historical Comparison
AMBA
PBLS

About AMBA Ambarella Inc.

Ambarella Inc is a developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge and physical artificial intelligence (AI) applications and intelligent automation. Its products are used in a wide variety of human viewing, computer vision for edge and physical AI applications, including a variety of video security cameras, automotive camera systems, fixed robots, autonomous mobile robots (AMRs), industrial applications, intelligent transportation systems, and consumer devices, such as action, drone and 360 degree cameras. The company operates as a single operating and reportable segment and derives substantially all of its revenue from development and sales of low-power AI-based processing and video and image processing SoC solutions.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: